Literature DB >> 19885748

Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer.

Langmei Deng1, Tao Su, Aimin Leng, Xiaomei Zhang, Meihua Xu, Lu Yan, Huan Gu, Guiying Zhang.   

Abstract

The aim of this paper was to identify novel proteins involved in the development of gastric cancer (GC). Isobaric tags for relative and absolute quantification (iTRAQ) analysis was adopted to separate the differentially expressed proteins between normal gastric epithelial cell line GES-1 and GC cell line SGC7901. Western blotting was utilized to validate the increased expression of sorcin in SGC7901; immunohistochemistry was performed to investigate its relationship with clinicopathological features of GC. Twelve differential proteins were identified. Seven proteins were found to be significantly upregulated (≥two-fold), while five proteins were markedly downregulated (≤0.5-fold), in SGC7901 cells. Sorcin was detected by this proteomic approach with a 5.4-fold upregulation in SGC7901. Western blotting and immunohistochemistry confirmed the overexpression of sorcin in GC. Immunohistochemistry showed us that sorcin was overexpressed in 55 samples of GC tissue (55/85, 64.71%) and was related closely to the depth of invasion, TNM stage, and lymph node metastasis of GC (P<0.05). The development of GC is regulated by multiple genes. Sorcin will be a novel molecular biomarker for the diagnosis, treatment, and prognosis of GC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885748     DOI: 10.1007/s12032-009-9342-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  27 in total

1.  Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype.

Authors:  Venkateshwar G Keshamouni; George Michailidis; Catherine S Grasso; Shalini Anthwal; John R Strahler; Angela Walker; Douglas A Arenberg; Raju C Reddy; Sudhakar Akulapalli; Victor J Thannickal; Theodore J Standiford; Philip C Andrews; Gilbert S Omenn
Journal:  J Proteome Res       Date:  2006-05       Impact factor: 4.466

2.  Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.

Authors:  Takashi Yokota; Jun Kouno; Koji Adachi; Hiroshi Takahashi; Akira Teramoto; Koshi Matsumoto; Yuichi Sugisaki; Masamitsu Onda; Tatsuhiko Tsunoda
Journal:  Acta Neuropathol       Date:  2005-11-30       Impact factor: 17.088

3.  A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line.

Authors:  Yi-Xuan Yang; Zhu-Chu Chen; Gui-Ying Zhang; Hong Yi; Zhi-Qiang Xiao
Journal:  J Cell Biochem       Date:  2008-06-01       Impact factor: 4.429

4.  Association of sorcin with the cardiac ryanodine receptor.

Authors:  M B Meyers; V M Pickel; S S Sheu; V K Sharma; K W Scotto; G I Fishman
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

Review 5.  Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.

Authors:  Xiaopan Zhang; Wenfang Xu
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease.

Authors:  Jianhua Zhang; Jianjun Sui; Chi Bun Ching; Wei Ning Chen
Journal:  Proteomics       Date:  2008-04       Impact factor: 3.984

7.  Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.

Authors:  Liviu Badea; Vlad Herlea; Simona Olimpia Dima; Traian Dumitrascu; Irinel Popescu
Journal:  Hepatogastroenterology       Date:  2008 Nov-Dec

8.  Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.

Authors:  Eri Mizuuchi; Shuho Semba; Yoshinori Kodama; Hiroshi Yokozaki
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

9.  Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction.

Authors:  J K Nagpal; B R Das
Journal:  Eur J Clin Invest       Date:  2007-08       Impact factor: 4.686

10.  ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis.

Authors:  T Kondo; K Takeuchi; Y Doi; S Yonemura; S Nagata; S Tsukita
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

View more
  17 in total

Review 1.  Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer.

Authors:  Bei-Bei Zheng; Peng Zhang; Wei-Wei Jia; Lu-Gang Yu; Xiu-Li Guo
Journal:  J Physiol Biochem       Date:  2012-06       Impact factor: 4.158

2.  Sorcin ablation plus β-adrenergic stimulation generate an arrhythmogenic substrate in mouse ventricular myocytes.

Authors:  Xi Chen; Craig Weber; Emily T Farrell; Francisco J Alvarado; Yan-Ting Zhao; Ana M Gómez; Héctor H Valdivia
Journal:  J Mol Cell Cardiol       Date:  2017-11-22       Impact factor: 5.000

3.  Differential expression of serum proteins in rats subchronically exposed to arsenic identified by iTRAQ-based proteomic technology-14-3-3 ζ protein to serve as a potential biomarker.

Authors:  Jin Hui Zhang; Ying Li; Xuan Bo Song; Xiao Hong Ji; Hong Na Sun; Hui Wang; Song Bin Fu; Li Jun Zhao; Dian Jun Sun
Journal:  Toxicol Res (Camb)       Date:  2016-02-01       Impact factor: 3.524

4.  Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Nazia Syed; Mustafa A Barbhuiya; Remya Raja; Arivusudar Marimuthu; Nandini Sahasrabuddhe; Sneha M Pinto; Srikanth Srinivas Manda; Santosh Renuse; H C Manju; Mohammed Abdul Lateef Zameer; Jyoti Sharma; Mariana Brait; Kotteazeth Srikumar; Juan Carlos Roa; M Vijaya Kumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha Vijay Kumar; Akhilesh Pandey; Harsha Gowda; Aditi Chatterjee
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.

Authors:  Anita Mangia; Lucia Caldarola; Stefania Dell'Endice; Emanuela Scarpi; Luca Saragoni; Manlio Monti; Daniele Santini; Oronzo Brunetti; Giovanni Simone; Nicola Silvestris
Journal:  Cancer Biol Ther       Date:  2015-06-30       Impact factor: 4.742

Review 6.  What gastric cancer proteomic studies show about gastric carcinogenesis?

Authors:  Mariana Ferreira Leal; Fernanda Wisnieski; Carolina de Oliveira Gigek; Leonardo Caires do Santos; Danielle Queiroz Calcagno; Rommel Rodriguez Burbano; Marilia Cardoso Smith
Journal:  Tumour Biol       Date:  2016-04-28

7.  High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients.

Authors:  Hao Huang; Yong Han; Jing Gao; Junnan Feng; Lei Zhu; Like Qu; Lin Shen; Chengchao Shou
Journal:  Med Oncol       Date:  2013-10-18       Impact factor: 3.064

8.  Filamin C, a dysregulated protein in cancer revealed by label-free quantitative proteomic analyses of human gastric cancer cells.

Authors:  Jie Qiao; Shu-Jian Cui; Lei-Lei Xu; Si-Jie Chen; Jun Yao; Ying-Hua Jiang; Gang Peng; Cai-Yun Fang; Peng-Yuan Yang; Feng Liu
Journal:  Oncotarget       Date:  2015-01-20

9.  Sorcin links calcium signaling to vesicle trafficking, regulates Polo-like kinase 1 and is necessary for mitosis.

Authors:  Vasiliki S Lalioti; Andrea Ilari; David J O'Connell; Elena Poser; Ignacio V Sandoval; Gianni Colotti
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

10.  Acupuncture Regulates Serum Differentially Expressed Proteins in Patients with Chronic Atrophic Gastritis: A Quantitative iTRAQ Proteomics Study.

Authors:  Feng Li; Bai Yang; Yanan Liu; Tianying Tang; Cun Wang; Mei Li; Siyi Lv; Qin Qi; Huirong Liu; Zheng Shi; Huangan Wu; Xiaomei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.